Philip M. Mayles

Clatterbridge Road
Wirral, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial.

Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial.

Journal: Clinical and translational radiation oncology

Published: December 24, 2019

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 17, 2019

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity.

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: February 05, 2019

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL).

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL).

Journal: International journal of radiation oncology, biology, physics

Published: July 19, 2018

Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer.

Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer.

Journal: BMJ open

Published: April 19, 2018

Letter regarding Meade et al. entitled "Models of acute mucosal tolerance to radiotherapy alone applied to synchronous chemo-radiation schedules in head and neck cancer".

Letter regarding Meade et al. entitled "Models of acute mucosal tolerance to radiotherapy alone applied to synchronous chemo-radiation schedules in head and neck cancer".

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: October 17, 2014

Separating components of variation in measurement series using maximum likelihood estimation. Application to patient position data in radiotherapy.

Separating components of variation in measurement series using maximum likelihood estimation. Application to patient position data in radiotherapy.

Journal: Physics in medicine and biology

Published: September 18, 2014

Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.

Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.

Journal: International journal of radiation oncology, biology, physics

Published: March 27, 2013

Progress with Intensity-modulated radiotherapy implementation in the UK.

Progress with Intensity-modulated radiotherapy implementation in the UK.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: May 28, 2012

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.

Journal: The Lancet. Oncology

Published: December 16, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026